Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,038,740
+$28,452 QoQ
Shares Held
6,628
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#606
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $244,605,118 across 14 Drug Manufacturers - General names. NVS ranks #13 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
210,285 | $53,406,081 | |
| 2 | LLY |
ELI LILLY & Co
|
37,094 | $44,491,660 | |
| 3 | MRK |
Merck & Co., Inc.
|
272,973 | $35,077,030 | |
| 4 | ABBV |
AbbVie Inc.
|
139,208 | $35,030,301 | |
| 5 | AMGN |
Amgen Inc
|
93,841 | $33,981,702 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
282,306 | $16,266,471 | |
| 7 | AZN |
Astrazeneca PLC
|
53,960 | $10,231,895 | |
| 8 | PFE |
Pfizer Inc
|
335,032 | $8,067,570 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,038,740 | 6,628 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,010,288 | 6,614 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $889,537 | 6,452 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $776,749 | 6,057 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $764,420 | 6,317 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $711,353 | 6,381 | Shares | Defined | 2025-05-01 | |
| 2024-12-31 | $630,958 | 6,484 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $737,853 | 6,415 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $751,288 | 7,057 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $672,853 | 6,956 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $694,168 | 6,875 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $703,648 | 6,908 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $736,743 | 7,301 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $676,016 | 7,348 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $606,916 | 6,690 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $620,165 | 8,159 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $754,430 | 8,925 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $838,012 | 9,550 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $1,069,933 | 12,232 | Shares | Defined | 2022-03-07 | |
| 2021-09-30 | $2,345,041 | 28,675 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $2,204,814 | 24,165 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,982,366 | 23,191 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,686,439 | 28,449 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,458,967 | 28,277 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,725,270 | 31,203 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $2,447,033 | 29,679 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||